FDA Panel Recommends Premarket Approval For IOP-Lowering Micro-Bypass Stent

Ocular Surgery News

Amid some concern about long-term efficacy, the U.S. Food and Drug Administration's Ophthalmic Devices Panel recommended premarket approval of the Glaukos iStent Trabecular Micro-Bypass Stent July 30.
  • <<
  • >>

Comments